Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Leases (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Leases over the past 11 years, most recently at $2.2 million for Q1 2025.

  • For Q1 2025, Leases fell 11.04% year-over-year to $2.2 million; the TTM value through Feb 2025 reached $2.2 million, down 11.04%, while the annual FY2024 figure was $2.4 million, 42.97% down from the prior year.
  • Leases for Q1 2025 was $2.2 million at Lifecore Biomedical, Inc. \De\, down from $2.3 million in the prior quarter.
  • Over five years, Leases peaked at $15.4 million in Q1 2021 and troughed at $2.2 million in Q1 2025.
  • A 5-year average of $5.6 million and a median of $5.1 million in 2023 define the central range for Leases.
  • Biggest five-year swings in Leases: crashed 62.97% in 2022 and later dropped 10.57% in 2023.
  • Year by year, Leases stood at $7.5 million in 2021, then fell by 29.87% to $5.3 million in 2022, then fell by 23.14% to $4.0 million in 2023, then plummeted by 42.91% to $2.3 million in 2024, then decreased by 3.08% to $2.2 million in 2025.
  • Business Quant data shows Leases for LFCR at $2.2 million in Q1 2025, $2.3 million in Q4 2024, and $2.4 million in Q3 2024.